Dr Mohammed Shaker

Research Fellow/Senior Research off

Australian Institute for Bioengineering and Nanotechnology
+61 7 334 63894


A neuroscientist, Dr Shaker received his PhD in 2017 from Korea University, Seoul-South Korea, after working on the cellular behaviour of embryonic neural stem cells during the brain and spinal cord development as well as axial elongation. Dr Shaker obtained the Brain Korea 21 Plus Fellowship from the Korea Univesity Medical School before being appointed in AIBN-UQ to work in Professor Ernst Wolvetang's laboratory as a Postdoctoral Research Fellow in Organoid Biology to continue his research into the importance of modelling the human central nervous system in health and disease using organoid technology. Dr Shaker demonstrated:

1- Successful generation of white matter like tissues in organoids, this tissue is enriched with myelinating oligodendrocytes, neurons and astrocytes (Shaker MR et al, Frontiers in Cellular Neuroscience 2021). This protocol is robust and rapid that involves a 42-day exposure of neuroectoderm-derived organoids to a cocktail of growth factors and small molecules that collectively foster oligodendrocyte specification and survival along with neurons and astrocytes. This platform prompted the discovery of NELL2 expression in human oligodendroglial cell types and NELL2 was further linked with human white mater development and diseases by using artificial intelligence prediction (Shaker MR et al, Frontiers in Cell and Developmental Biology, 2022).

2- Human cortical organoids develop the typical hallmarks of senescent cells when maintained in vitro for prolonged periods of time, and moderate upregulation of endogenous KL expression in cortical organoids inhibits neuronal senescence (Shaker MR et al, NPJ Aging and Mechanisms of Disease 2021). This platform offers new mechanistic insight into its role in human brain ageing.

3- Successful modelling Down Syndrome using patient and isogenic human iPSCs lines with Choroid Plexus-Ventricle-Cortical organoid. (Shaker MR et al, BioRxiv 2023), this model is useful for dissecting the role of the choroid plexus in euploid and DS forebrain development and enables screening for therapeutics that can inhibit SARS-CoV-2 induced neuro-pathogenesis.

Currently, Dr Shaker is working on two main projects:

1- Modelling leukodystrophy using 4 reprogrammed patients' iPSCs lines with an oligodendrocyte brain organoid.

2- Modelling children with defects in neural tube elongation using spinal cord organoids. This research program will use organoid technology combined with cutting-edge transcriptomics techniques to understand the cellular processes driving neural tube elongation. This will improve our capacity to how cells arrange into a continuous elongating neural tube to provide insight into the cause of defects in human neural tube.

Research Interests

  • Neurogenesis
  • Myelination
  • Organoids
  • Neural tube
  • Mitochondria


  • Doctor of Philosophy
  • Masters (Coursework), University of Malaya
  • Bachelor of Biomedical Science, University of Malaya


View all Publications


  • Doctor Philosophy

  • Doctor Philosophy

View all Supervision


Journal Article

Conference Publication

PhD and MPhil Supervision

Current Supervision